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Sumnlary 
CD4-CD8-  (double negative [DN]) o~//3 T cells are a largely uncharacterized subpopulation 
of unknown function. To investigate whether these cells are selected to recognize particular antigens 
or antigen-presenting molecules, DN ot/B T  ceils were purified from the peripheral blood of 
five normal donors and their T  cell receptor (TCR) o~ and/~ chains were examined. Random 
cloning of TCR o~ chains by single-sided polymerase chain reaction (PCR) amplification identified 
an invariant  rearrangement between Vot24 and Jc~Q, with no N  region diversity, which was 
expressed preferentially by DN c~/~ T  cells from all donors. Random cloning also identified 
a precise VoH.2-Jc~(IGRJa14) rearrangement, with two variable amino acids encoded in the V-J 
junction, which was enriched in the DN cr  T cell preparations from some, but not all, donors. 
Analysis of TCR/3 chains by quantitative PCR amplification demonstrated that the expression 
of four Vfl gene families, V/32, 8, 11, and 13, was markedly increased in these DN c~/B T cell 
preparations. The expression of particular TCRs by DN ol/~ T cells from multiple donors indicates 
that these ceils, or at least a subpopulation of cells with this phenotype, recognize a limited 
spectrum of antigens and suggests that they may use nonpolymorphic  antigen-presenting  molecules. 
H 
uman peripheral blood contains small numbers ofT cells 
that express the TCR c~//3, lack CD4, and express low 
or undetectable levels of CD8 (1-4).  These double-negative 
(DN) 1 c~/~ T cells comprise <1% of the T cells in normal 
peripheral blood from most donors, but their numbers may 
be higher in some tissues, in partictdar epidermis (5). Increases 
in DN o~//3 T cells have been observed in patients with SLE 
(2) and systemic sclerosis (6), in rare immunodeficient pa- 
tients with a graft-vs.-host-like disease (7), and in occasional 
normal donors (3). These cells are also massively increased 
in Ipr and gld mice, which share features of human autoim- 
mune disease (8, 9). However,  the normal function of DN 
cr  cells and the role they may play in autoimmune diseases 
are uncertain, nor is it dear if they represent a functionally 
or developmentally  discrete subpopulation of mature T ceUs. 
A small population of mature DN c~/B T calls is also found 
in murine thymus (10-16) and peripheral lymphoid tissues 
1 Abbreviations used in this paper: DEC, dendritic epidermal T cell; DN, 
double negative;  HS,  human serum. 
(15, 17-19).  Investigations of TCR V3 expression by these 
cells have demonstrated preferential  usage of V38 in some 
strains of mice (10-12,  14). A second population of murine 
DN or/3 T cells that preferentially expresses V32 has been 
demonstrated in bone marrow (20, 21). Studies of DN c~//3 
T cells in strains of mice expressing endogenous superantigens 
(19) and in mice with an autoreactive transgenic TCR (22, 
23) suggest that these cells are selected  by a mechanism different 
from  that  operating  on  CD4+8 -  and  CD4-8 +  (single- 
positive) T cells. These observations suggest that routine DN 
c~/~ T  cells may represent a developmentally distinct sub- 
population of T lymphocytes, perhaps mediating a special- 
ized function. 
Murine and human T cells with the DN ot/~ TCR pheno- 
type have been identified that can carry out several effector 
functions (4, 24-32), but the precise antigens recognized by 
these cells have not been defined in most cases. The absence 
of CD4 and CD8 expression suggests that these cells, or a 
subpopulation of cells with the DN cr/B TCR phenotype, 
may use antigen-presenting molecules other than the clas- 
sical MHC class I or II proteins. Consistent with this hy- 
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Volume  178  July 1993  1-16 pothesis, the nonpolymorphic MHC-like CD1 molecules have 
been identified as the ligands for several human DN or~3 T 
cell clones (4,  32). 
One approach to address the question of whether specific 
antigens or antigen-presenting molecules are recognized by 
human DN o~/3 T cells is to identify the TCRs used by these 
cells. If the function of DN or/3 T cells involves recognition 
of a limited number or specific type of antigen, or if antigen 
presentation to these cells is carried out by proteins other 
than the classical MHC class I and II molecules, then the 
TCRs expressed by these cells may use particular V region 
genes or have some common structural features in their V-J 
joints. In this study, TCR expression by freshly isolated DN 
c~/~ T  cells was assessed using a combination of random 
cloning,  sequencing,  and  quantitative PCR  amplification 
methods. This analysis identified at least two TCR c~ chains 
with distinctive structural features that were expressed pref- 
erentially by purified DN o~/3 T cells from multiple donors. 
VB usage by DN o~/~ T cells was also biased towards a small 
number of  V3 gene families in each donor. These results dem- 
onstrate distinctive features of TCRs expressed by DN com- 
pared with single-positive ol//~ T  cells and provide further 
evidence  that DN c~/[3 T  cells may carry out a specialized 
immunological function. 
Materials  and Methods 
Isolation of  DN oz/~ T Cells.  Leukocyte  concentrates of  human 
peripheral blood were obtained as a byproduct of plateletpheresis 
of randomly selected healthy blood donors. PBMC were purified 
by Ficoll-Hypaque  gradient centrifugation (lymphocyte  separation 
medium; Pharmacia Fine Chemicals, Piscataway, NJ). A total of 
4-14  x  10  s PBMC were suspended at 5  x  107 cells/ml in PBS 
containing 2% human serum (HS) and a 1:1,000 dilution of ascites 
fluid containing mAbs OKT4 (anti-CD4) (33) and OKT8 (anti- 
CD8o  0 (33), and incubated on ice for 2 h. Cells were then pdleted 
by centrifugation, resuspended in 25 ml of 20% rabbit serum (Ac- 
curate Chem. & Sci. Corp., Westbury, NY), diluted in RPM11640 
(Gibco Laboratories,  Grand Island, NY) as a source  of complement 
activity, and incubated 1 h at room temperature followed by an 
additional  15  min  at  37~  Viable cells were collected after 
complement-mediated lysis by Ficoll-Hypaque centrifugation and 
cultured at 2.5  x  10  s cells/ml in RPMI 1640 +  10% FCS in a 
single 150-cm  2 tissue culture flask. After incubation for 90 min 
at 37~  nonadherent cells  were collected,  washed, and resuspended 
at 5 x  107 cells/ml in PBS +  2% HS with 1:500 dilutions of as- 
cites fluids containing mAbs OKT4, OKT8, and (in four of five 
preparations) anti-TCR 51 (specific  for the C region of the TCR 
/~ chain) (34). After incubation on ice for 1 h, the cells were washed 
twice and resuspended at 2 x  107 cells/ml in PBS +  2% HS con- 
taining 6  x  107/ml goat anti-mouse Ig-coupled magnetic beads 
(Dynabeads M450; Dynal, Inc., Great Neck, NY). The mixture 
of cells and magnetic beads was incubated with gentle agitation 
on an orbital shaker  for 1 h at 4~  after which the beads and bound 
cells  were removed by  magnetic  separation.  Unbound  cells 
representing purified CD4-8- nonadherent (and TCR ~5- in four 
of five cases) PBMC were collected, analyzed for purity by flow 
cytometry, and used for preparation of total cellular RNA. 
Flow Cytometry Analysis.  Aliquots  of purified CD4-8- nonad- 
herent PBMC and unfractionated PBMC from each donor were 
stained with mAbs for two-color flow cytometry analysis  as previ- 
ously described (35). CD4 and CD8 expression was assessed using 
a mixture of FITC-conjugated mAbs Leu-3a (anti-CD4; reference 
36) and B9.2 (anti-CD8~v; reference  37), each diluted to 10 #g/ml. 
These particular anti-CD4 and -CD8 mAbs were chosen because 
they bind to epitopes that are not blocked  by the OKT4 and OKT8 
mAbs used in the immunoselection procedure of CD4-8-  cells 
(S. Porcelli, unpublished data). Expressions of CD3, TCR ~/~, 
and TCR "//5 were assessed  using biotin-conjugated mAbs OKT3 
(anti-CD3e; reference  33), BMA-031 (anti-TCR ~/B; reference  38) 
and anti-TCR 51, each diluted to 2/zg/ml. Binding of  biotinylated 
mAbs was  detected by staining with a  1:500 dilution  of PE- 
conjugated Streptavidin  (Tago, Inc., Burlingame,  CA). Background 
staining was determined using FITC and biotin conjugates of IgG1 
myeloma  protein P3 (39). Immunofluorescence  was analyzed  using 
a FACScan  |  flow cytometer (Becton Dickinson & Co., Mountain 
View, CA). 10,000 cells of each sample were analyzed using for- 
ward and 90  ~ light scatter gates to select for lymphocytes. 
Preparation of Whole CeUular  RNA and cDNA.  For each of the 
five different donor preparations analyzed,  between 1 and 5 x  107 
purified CD4-8- nonadherent PBMC were used for cDNA prep- 
aration. For each donor, an identical number of unfractionated 
PBMC was used. Whole cellular RNA was extracted in 3 M 
LiC1/6 M urea and first-strand cDNA synthesis was carried out 
using  oligo(dT) priming  and Moloney murine leukemia virus 
(M-MLV) reverse transcriptase (Bethesda Research Laboratories, 
Gaithersburg, MD), as described (40). 
Single-sided PCR Amplification and Cloning.  TCR ol transcripts 
were randomly  cloned  using a modification  of  the rapid amplification 
of cDNA ends (RACE) (41) or anchored PCR methods (42), as 
described previously (40). Aliquots of cDNA from the DN cl/3 
T cell preparations were homopolymer tailed with terminal deox- 
ynucleotidyltransferase (TdT) and  deoxycytosine triphosphate 
(dCTP), as described  (40). Second-strand  synthesis was carried out 
using the Kienow fragment of DNA polymerase I and an oligo- 
(dG) primer (GATAGTCGACGGGGGGGGGG,  SalI-dG10) (40). 
TCR ce chains were then amplified  by PCR using an antisense Cce 
primer located at the 3' end of the C region (GAGGGAGCACA- 
GGCTGTCTT) and the nonspecific SalI-dG10 primer (40). The 
PCR products were than reamplified  using internal antisense Cc~ 
primers in conjunction with the SalI-dG10  primer. The internal an- 
tisense Cce primers were either  GGCAGACAGACTTGTCAC- 
TGGAT or GAAAGTTTAGGTTCGTATC'I'G'ITI~A,  located  just 
3' to PvulI (Col-pre-Pvu II) or HindlII sites (C~-pre-HindlII) in 
Cc~, respectively.  The PCR products were then digested with SalI 
and PvulI or HindlII, and cloned into pBluescript (Stratagene, La 
Jolla, CA). Positive  colonies were identified  by hybridization with 
an internal C~ probe (CGGCAGGGTCAGGGTTCT) and mul- 
tiple isolates were then picked and sequenced. 
PCR Amplification and Cloning of  Specific Voz Transcripts.  Anti- 
sense primers specific for Vc~7.2 (TCCTTCGTCGGTCTAAAG- 
GGTACA), Vce23 (AGTGGAAGACTTAATC~CTCGCT), and 
Vce24 (GATATACAGCAACTCTGGATC~A)  (43) were used in 
conjunction with the 3' Co~ primer to amplify  by PCR the respec- 
tive Vczs. The PCR reactions contained cDNA, 20 pmol of each 
primer, 0.1 mg/ml BSA, 0.2 mM dNTPs, 1.5 mM MgC12, 1 U 
Taq polymerase (Promega Biotec, Madison, WI), and buffer sup- 
plied by the manufacturer in a final  50-/A volume. Each cycle was 
94~  for 20 s, 55~  for 30 s, and 72~  for 90 s for 30 cycles. 
In some cases, 1/A of the PCR product was reamplified  using an 
internal Ccr primer located 3' to the HindIII site in Cce (see above). 
The ends of the PCR products were then blunted with T4 DNA 
polymerase, digested with HindIII, and cloned into pBlueseript. 
2  TCR Expression by Human Double-Negative er  T Cells Quantitative PCR Amplification of Vot Transcripts.  PCK ampli- 
fications with a pair of Ca primers were carried out initially on 
cDNA from PBLs and DN Ot//~ T cells to estimate the relative 
amount of total TCK ot cDNA in each sample. The 5' sense Cot 
primer was CCAGAACCCTGACCCTGCAGT  and the Cot-pre- 
HindlII oligonucleotide was the 3' antisense primer. PCK reac- 
tions were carried out in 20 #1 containing 100 ng of each primer, 
using the buffer and conditions described above. The PCK reac- 
tions were carried out for 24, 30, and 36 cycles, and the products 
were hybridized with an internal oligonucleotide probe (Cot-pre- 
PvulI). The relative amount of cDNA in each sample was esti- 
mated at a cycle number before the reaction reached a plateau. 
Approximately  equal amounts ofcDNA from each sample (based 
upon the above Cot amplifications) were then amplified by PCK 
with the Vot7.2, 23, or 24 primer in conjunction with the an- 
tisense, Cot-pre-HindlII primer. The PCK reactions contained 15 
pmol of each primer in 30 #1 and were carried out for 26 and 32 
cycles. The products were analyzed by Southern blot with an in- 
ternal otigonucleotide probe (Cc~-pre-PvulI) and quantitated on 
a Phosphorimager  (Molecular  Dynamics,  Inc., Sunnyvale,  CA). The 
lower cycle  number was used to quantitate; the higher cycle  number 
was used only to confirm that the reactions had not reached a pla- 
teau at the lower number of cycles. In every experiment, the Cot 
amplification  was repeated with each cDNA to precisely  normalize 
for the amount of cDNA. The results were expressed as the ratio 
of Vot/Cot in the DN population divided by the ratio of Vot/Cot 
in the matched PBLs. 
To estimate the frequency of each Vot in the PBLs, the eflqcien- 
cies of the Cot versus the Vet amplification primer pairs were com- 
pared. Plasmids containing full-length Vot7.2, 23, or 24 TCK ot 
cDNAs (V and C region) were amplified  by PCR using the pair of 
Cot primers or the Cc~ and appropriate Vot primers. The amount 
of product amplified  by each primer pair, using an identical amount 
of template, was then compared. The efficiency  of each Vot-Cot 
pair was calculated as the ratio of Vc~ product/Cot product. The 
frequency of each Vot in the PBL samples was then estimated by 
taking the ratio of Vot/Cot products amplified from PBL cDNA 
and dividing by the efficiency  of the respective primer pair. 
Analysis of TCRs Amplified by PCR on High-Resolution Polyacryl- 
amide Gels.  TCR c~ chains were first amplified  with the Ccz-pre- 
HindlII primer and a specific  Vot primer, as described above. The 
PCR products (0.5/xl) were then reamplified  in 20/~1 containing 
the same Vot primer, an internal antisense Cot primer located at 
the 5' end of the C region (CGGCAGGGTCAGGGTTCT, 100 
ng),  buffer, nucleotides, and  enzyme as above, and  0.1  t*l of 
[32p]dCTP (3,000 Ci/mmol, 10 mCi/ml). Alternatively, in some 
experiments the internal Cot primer was end labeled with 32p, 
using polynucleotide kinase. Each cycle was 94~  for 20 s, 48~ 
for 30 s, and 72~  for 30 s, for 20-25 cycles. The products were 
denatured by heating to 80~  in 50% formamide and run on a 
6% polyacrylamide  DNA sequencing  gel. Analysis  of  VB transcripts 
was carried out similarly  using external (GCCTTTTCCCTGTGG- 
GAGAT) and internal (GGCTCAAACACAGCGACCT)  antisense 
CB primers. The spacing of the TCK bands was determined by 
running DNA sequencing ladders next to the TCR samples. 
Quantitative PCR Amplification of VI3 Transcripts.  A series of 
VB-spedfic primers and PCR amplification were used to estimate 
the expression of each V/3 gene family (40, 44, 45). The DN ot//3 
T cell eDNA were amplified  in a series of  30-/,1 reactions  containing 
cDNA, 10 pmol of a CB antisense primer (GCCTTTTCCCTG- 
TGGGAGAT), 10 pmol ofa V/3 primer (see below), 0.1 mg/ml BSA, 
0.5 U Taq polymerase  (Promega  Biotec), 0.2 mM dNTPS, and buffer 
supplied by the manufacturer. Each cycle  was 94~  for 20 s, 55~ 
for 30 s, and 720C for 60 s. Aliquots of 5/xl were withdrawn after 
24, 30, and 36 cycles and hybridized with a 32P-labeled internal 
antisense C/~ probe (GGCTCAAACACAGCGACCT).  Quantita- 
tion was performed on a Phosphorimager (Molecular Dynamics, 
Inc.) after 24 or 30 cycles. The 36-cycle  aliquots were useful only 
to confirm that the reactions had not reached a plateau at the lower 
cycle numbers. Each V/~ was expressed as a percent of the total 
product amplified by all of the V/~ primers. 
One- or twofold degenerate primers were synthesized to recog- 
nize all members of each V/3 gene family (V/31-20), except V/36, 
which required two primers to recognize all members. The TCR 
nomenclature is based on reference 46, unless otherwise indicated. 
The VB primers were VB1, GAGAGCAAAAGGAAACATTCT- 
TGAAC; V~2, GC~CACATACGAGCAAGC-CGTC;  VB3, GGA- 
GATATTCCTGA(GA)C,-C_~TACA;  V~4, CCACATATGAGAGTG- 
GATTTGTCA; V/~5, GATI~TCAGCTCGCCAGTTC(TC)CTA- 
ACT; V~6,  CAGTGATCGCTTCT(TC)TGCAGA, GTC_~GG- 
CAGATGACTCA~q2  VB7, GCTTCTCACCTGAATGC- 
CCCAACA; V/38, GATAGATGATrCA~ATC~CCGA; V~9, 
TTATAAATGAAACAGTTCCAAATCGCT; V/310, TTCAGA- 
AAGCAGAAATAATCAATGAG;  VEIl, GAGAAGC~AGATCTT- 
TCCTCTGA;  V~I2,  TACTGACAAAGGAGAAGTCTCAGA; 
V~I3, CCCT(AG)ATC.~.~TACAATGTCTCCAGAT,  V/314, CI~ 
ATAAGGGAGAq~TTCCTGAAG;  V/315, GATGTGAAAGATATA- 
AACAAAGGAGAGA;  V~16, GATAATCTTTATCGACGTGTT- 
AIV_,GGA; VB17, GAAAGGAGATATAGCTGAAGGGTAC;  V1318, 
GTCAGGAAqV~CAAAGGAACGATI~ V1319, GAAACGGAG- 
ATGCACAAGAAGCGA;  V/320, GCCTCCAGCTGCTCTTCT- 
ACTCCA. 
Results 
Enrichment  of DN  ot/~  T  Cells from  Human  Peripheral 
Blood.  Preparations of PBLs enriched for CD4-8-  TCR 
or//8 + T  cells (DN c~//3 T  cells) from five random donors 
were prepared by extensive depletion of CD4 + ,  CDSc~  +, 
and plastic-adherent cells from PBMC.  In four of the five 
preparations (donors 1-4), T cells expressing TCR 3//6 were 
also depleted. An example of two-color flow cytometry anal- 
ysis of one representative preparation is shown in Fig. 1, along 
with an identical analysis of the unfractionated PBMC for 
the same donor. Contrary to the earlier description of re- 
duced TCR levels on murine peripheral lymph node DN c~/B 
T  cells (19), human peripheral blood DN ot/B T  cells ex- 
pressed the same level of TCR as did their CD4 + or CD8 + 
counterparts (Fig.  1). 
The enrichment of DN or//3 T calls in the CD4- and CD8- 
depleted preparations  (DN  samples)  relative to  the corre- 
sponding unfractionated PBMC (PBL samples) from the same 
donor is shown in Table 1 for each of the five preparations. 
DN or//3 T cells comprised <1.5% of the total lymphocytes 
and <2.0%  of the TCK or//3 + cells in all five donor PBL 
samples. In the five DN samples, DN or//3 T calls accounted 
for >94% of the total TCR or//3 + calls, representing an en- 
richment of between 50-  and 136-fold  relative  to PBL. In 
preparations from which TCR 7/6 + cells were specifically 
depleted (donors 1-4), DN or//3 T  cells represented >90% 
of the total T  cells (CD3+), whereas in the single prepara- 
tion lacking depletion of TCR 3//6 + cells (donor 5),  these 
represented 21.8%  of the CD3 + cells. 
3  Porcelli  eta]. TOTAL PBL  DN/TCR 6- PBL 
('9 
rm ￿84 
o 
rr 
o 
I-- 
rr 
(9 
I.- 
~.~ 
o 
I- 
T 
CD4 + CD8  CD4 + CD8 
Figure  1.  FACS  |  analysis of PBLs and purified DN c~//3 T cells from 
donor 1. Unfractionated  PBLs and purified DN c~/~ T cells from donor 
I were analyzed for expression of CD3, TCR oe/13, TCR 3'/8, CD4, and 
CDS. On the horizontal axis in all samples  is a mixture of FITC-conjugated 
CD4 and CD8 antibodies (CD4  +  CD8). The horizontal  and vertical 
cursors were placed to yield <1% positive cells with control antibodies. 
The horizontal  and vertical scales are log10 fluorescence intensity. 
In all of the DN samples, the majority of the lymphocytes 
were CD3-, and probably represented non-T lymphocytes, 
including B and NK cells. Since these CD3-  lymphocytes 
express low or undetectable levels of rearranged TCR (x or 
t3 chain transcripts, their presence would be predicted to have 
no effect on the analysis of these transcripts  (47, 48). Simi- 
larly, the presence of TCR 3,//} + cells in the DN prepara- 
tion from donor 5 should not significantly affect the TCR 
c~/B analysis, since TCR a  transcripts are absent from the 
vast majority of 3'//~ T cells and TCR ~ gene rearrangements 
are not expressed at high levels (49). 
Single-sided PCR Amplification,  Cloning, and Sequencing of 
TCR cr Chains from DN cr/fl T Cells.  The initial aim was 
to sample the TCR a  chains expressed by DN c~/~ T cells 
and determine if particular  Va genes were expressed at an 
increased frequency relative to single-positive PBLs. A con- 
cern in analyzing TCR o~ chains from minor subpopulations, 
such as DN ol//3 T cells, was that they could use previously 
undescribed  Vcr  genes. A  single-sided PCR amplification 
method (40-42)  was used initially, therefore, to randomly 
clone and sequence  all potential TCR c~ chains from two prepa- 
rations of DN a/~ T cells. Using this approach, it would 
be expected that Vex genes enriched in the DN a//3 T cell 
population would be found in multiple independent clones. 
A total of 48 TCR cx chains were sequenced, 29 from donor 
I and 19 from donor 2. Two new Vc~s were identified, but 
they were only single isolates and their expression by DN 
o~//3 T cells was not, therefore, characterized further (data 
not shown). Three previously described Vc~s were, however, 
used by multiple TCRs (Table 2). TCKs using Va24 (43) 
were isolated 14 times from the first donor (48% of isolates 
from this donor) and once from the second donor.  In the 
majority of these isolates from donor 1 (12/14) and in the 
single isolate from donor 2, Va24 was recombined with JoeQ. 
Moreover, no V-J junctional diversity was evident in any of 
these 13 Vo~24-JtxQ recombinations. 
The isolation of the identical Vo~24-JoLQ recombination 
from donors 1 and 2 (Table 2) and subsequently from three 
additional donors (Table 3, see below) suggested that they 
may represent precise rearrangements of the germline Voe24 
and JoLQ genes, with minimal or no N region additions or 
deletions. The germline sequence of Vc~24 is not available, 
but the multiple Va24 cDNA isolates in Tables 2 and 3 (see 
below) indicate that the 3' end of the Vol24 gene is at the 
AGC (encoding serine), as shown in Table 2. The structure 
of the JolQ gene can be deduced from a germline Jc~Q tran- 
script we have isolated and sequenced (Fig. 2). Similar germ- 
line transcripts encoding other Jc~s have been described pre- 
viously and presumably initiate from a promoter upstream 
of the unrearrangedJot gene (43, 50). A comparison between 
Table  1.  Frequency of CD4-8-  TCR  cr/fl + Lymphocytes in Cell Preparations Used for TCR Analysis 
Donor 
CD4-8-  TCtL a//3 + in PBL  samples 
Percent of total  Percent of CD3 +  Percent of TCR a/B + 
lymphocytes  lymphocytes  lymphocytes 
CD4-8-  TCR ollfl § in DN samples 
Percent of total  Percent  of CD3 §  Percent  of TCR ~/fl+ 
lymphocytes  lymphocytes  lymphocytes 
1  1.0  1.3  1.4  7.0  97.2  97.2 
2  1.4  1.9  1.9  7.6  90.5  97.4 
3  0.5  0.6  0.7  4.1  93.2  95.3 
4  1.3  1.7  1.7  3.0  94.9  98.7 
5  1.4  1.9  1.9  5.4  21.8  94.7 
4  TCR Expression by Human Double-Negative  ~/B T  Cells T
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 TTTTCAACCCTGTACTCCAAAGCTGAGGGGAGAGGGGATGGGAAACATTAAGGGCTGGGTTCATG 
aspargg  lyser  thr  leuglyarg  leutyrpheg  lyargg  lyth 
TAAAGGGACCAGCATTGTGCCGACAGAGGCTCAACCCTGGGGAGGCTATACTTTGGAAGAGGAAC 
rg  in  leuthrva  itrpproaspile 
TCAGTTGACTGTCTGGCCTGATATeC  -e~ 
Figure 2.  Nucleotide sequence of a germline JolQ-Cot transcript.  A 
cDNA containing the J~ gene spliced precisely to Ca was isolated by 
single-sided PCR amplification.  The sequence of the 5' upstream  region, 
complete J~, and the 5' end of Col are shown. The heptamer and nonamer 
recombination sequences are underlined and the 5' end of Ca is boldfaced. 
the Vot24-JotQ rearrangement in Table 2 and the germline 
JotQ gene in Fig. 2 shows that this Vot24-JotQjoint  contains 
the entire JotQ gene segment except for the two cytosines 
immediately after the heptamer recombination signal. The 
generation of this invariant Vot24-JotQjoint  required, there- 
fore, the deletion of two bases but no N  region additions. 
A second Vot isolated multiple times from both donors 
was Vot7.2 (43) (Table 2). In the majority of these TCRs, 
Vot7.2 was joined to IGRJa14 (43) (4/5 from donor 1 and 
4/4 from donor 2). Furthermore, these V-J joints were similar 
in that they occurred to the same nucleotide in IGRJa14 and 
appeared to contain six N region nucleotides. Alternatively, 
the Vot7.2 gene shown in Table 2 may encode several addi- 
tional 3' bases (G or GT being most likely; see below). In 
either case, the TCR ot chains encoded by these transcripts 
had the 3' alanine in Vot7.2 and two variable amino acids 
in the V-J junction joined precisely to the 5'  aspartate in 
IGRJa14. Interestingly, the only Vot7.2 isolate that was joined 
to a different J was out of frame (Table 2, donor 1), further 
indicating that this rearrangement to IGRJa14 predominates 
among functional Vot7.2 rearrangements. 
The third Vot identified more than once was Vot23 (43), 
which occurred in three isolates from each donor (Table 2). 
A previously undescribed Jot, Jot8A1, was used by one of these 
Vot23 TCRs from each donor, but each of these Vot23-Jot8A1 
TCRs had a distinct N  region and the rearrangement was 
out of frame in donor 1. There were otherwise no noteworthy 
similarities between the TCRs using Vot23. 
Analysis of VotT.2, 23, and 24 Expression by Quantitative  PeR 
Amplification.  To confirm the results from random cloning, 
the expression of Vot7.2, 23, and 24 by donors 1 and 2 and 
by three additional donors was assessed  by quantitative PCR 
amplification. The frequency of these Vots in unfractionated 
PBLs from each donor was first assessed. Primers specific for 
Vot7.2, 23, or 24, in conjunction with a Cot primer, were 
used to amplify PBL cDNA from each of the donors. Two 
specific Cot primers were used to estimate the total amount 
of TCR ot cDNA, and the efficiencies of the Vot primers 
versus the Cot primers were determined (see Materials and 
Methods). This analysis indicated that the Vot7.2 transcript 
varied from 3.0 to 10% of the total TCR ot cDNA in PBLs 
from these five donors, while the Vot23 and Vot24 transcripts 
were between 2.2 and 6.5%  (data not shown). These fre- 
quencies were consistent with the results from random cloning 
of TCR ot chains using these Vots from peripheral blood (43). 
The expression of these Vots in the DN population versus 
the PBLs from the same donor was then compared to deter- 
mine if any were enriched in the DN population, cDNA from 
the DN and corresponding unfractionated PBL samples were 
used as templates for quantitative  PCR amplification using 
primers specific  for Vot7.2, 23, or 24. The amplifications were 
normalized in each experiment by amplifying parallel samples 
with two Cot primers.  The amount of PCR product was 
quantitated and the ratio of DN versus PBL transcripts was 
calculated. 
Fig. 3 shows that the expression of Vot7.2 and Vot24 by 
DN ot/3 T cells was increased  relative to PBLs in the majority 
of donors, although most of the increases  were less than four- 
fold. In contrast, Vot23 was not increased in any of the DN 
ot/3 T  cell preparations,  indicating a discrepancy between 
the random cloning method (Table 2) and this quantitative 
PCR method in assessing the expression of Vot23 by donors 
i  and 2. The reason for this discrepancy is not clear, but it 
emphasizes the need for a second method to confirm results 
derived from random cloning. The frequencies of the Vot7.2 
and Vot24 transcripts in the DN ot/3 T cell populations from 
donors 1 and 2 estimated by this quantitative  PCR method 
were, however, consistent with the random cloning results 
(Table 2). Both methods indicated that TCRs using Vot7.2 
were frequent transcripts in donors 1 and 2 and that TCRs 
using Vot24 were particularly  abundant in donor 1. 
Sequence Analysis of TCR ol Transcripts  from PBLs and DN 
ot/fl T Cells Using Vet7.2 and Vo124.  Although the expres- 
sion of the Vot7.2 and Vot24 transcripts was not markedly 
increased in most of the DN ot/3 T cell preparations relative 
to the PBLs, the sequencing data in Table 2 also indicated 
that DN ot/3 T cells using Vot7.2 and Vot24 may select par- 
ticular Jot genes and junctional sequences. To further assess 
the expression of Vot7.2 and Vot24 and determine if they 
undergo precise rearrangements with specific  Jot genes in DN 
ot/3 T cells, multiple additional TCRs using these Vots were 
EXP.  1 
8 
7 
--I 6 
~s 
54 
[33 
2 
Vr  I  Vc~7.2  !  Vo,'23 
12345  12345  12345 
EXP.  2 
8 
7 
4 ~ 
5  ~4 
~3 
2 
1- 
V~7.2  vor23 
n?NI  ][J~I .......  ~  .... 
12345  12345  12345 
DONOR 
Figure  3.  Comparison of V~7.2, 23, and 24 expression by DN o~/3 
T cells versus PBLs. The expression of each V~ relative to Co~ in the DN 
and PBL samples was estimated by quantitative PCR amplification.  The 
ratio of V~ expression in the DN versus the matched  PBL samples was 
then determined.  The results  from two experiments  are shown. 
8  TCR Expression  by Human Double-Negative el~3 T  Cells T
a
b
l
e
 
4
.
 
S
e
q
u
e
n
c
e
s
 
o
f
 
T
C
R
s
 
U
s
i
n
g
 
V
o
t
7
.
2
 
f
r
o
m
 
D
N
 
a
t
/
j
8
 
T
 
C
e
l
l
s
 
a
n
d
 
P
B
L
s
 
P
r
e
c
i
s
e
 
V
c
=
7
.
2
-
I
G
R
J
a
1
4
 
j
o
i
n
t
s
 
N
 
r
e
g
i
o
n
 
D
o
n
o
r
 
N
 
r
e
g
i
o
n
 
O
t
h
e
r
 
Y
a
7
.
2
 
j
o
i
n
t
s
 
J
 
r
e
g
i
o
n
 
D
o
n
o
r
 
r
 
.
=
.
 
G
T
G
A
A
G
 
(
v
a
l
l
y
s
)
 
D
N
1
 
G
T
G
A
G
A
 
(
v
a
l
a
r
g
)
 
D
N
1
 
G
T
G
G
G
G
 
(
v
a
l
g
l
y
)
 
D
N
1
 
G
T
A
C
T
G
 
(
v
a
l
l
e
u
)
 
D
N
1
 
G
T
G
G
T
G
 
(
v
a
l
v
a
l
)
 
D
N
2
 
G
G
C
T
G
G
 
(
g
l
y
t
r
p
)
 
D
N
2
 
G
G
C
A
T
G
 
(
g
l
y
m
e
t
)
 
D
N
3
 
G
T
G
A
A
G
 
(
v
a
l
l
y
s
)
 
D
N
4
 
G
T
G
A
G
A
 
(
v
a
l
a
r
g
)
 
D
N
4
 
G
T
C
A
T
G
 
(
v
a
l
m
e
t
)
 
D
N
4
 
G
T
G
A
T
G
 
(
v
a
l
m
e
t
)
 
D
N
4
 
G
T
G
A
T
G
 
(
v
a
l
m
e
t
)
 
P
B
L
1
 
A
T
C
A
T
G
 
(
i
l
e
m
e
t
)
 
P
B
L
1
 
G
T
G
A
G
A
 
(
v
a
l
a
r
g
)
 
P
B
L
2
 
G
C
G
G
T
G
 
(
a
l
a
v
a
l
)
 
P
B
L
2
 
C
T
A
C
T
C
 
(
l
e
u
l
e
u
)
 
P
B
L
3
 
G
T
A
A
G
A
 
(
v
a
l
a
r
g
)
 
P
B
L
4
 
A
C
A
A
T
G
 
(
t
h
r
m
e
t
)
 
P
B
L
4
 
G
T
G
A
G
A
 
(
v
a
l
a
r
g
)
 
P
B
L
4
 
G
T
G
A
G
A
G
A
T
G
A
G
T
A
 
G
T
G
G
C
C
T
T
A
G
G
G
 
G
T
C
C
T
C
 
G
T
G
A
G
A
G
T
T
 
G
C
T
 
G
T
G
A
C
C
T
T
G
G
A
C
A
C
G
 
G
T
G
A
G
A
G
A
T
C
G
G
G
 
C
A
A
T
A
A
C
A
A
T
G
A
C
A
T
G
C
G
C
T
T
T
G
G
A
-
 
I
G
R
J
a
l
O
 
D
N
1
 
G
G
G
G
G
T
T
A
C
C
A
G
A
A
A
G
T
T
A
C
C
T
T
T
G
G
A
-
 
J
e
O
 
P
B
L
1
 
A
A
T
T
C
C
G
G
G
T
A
T
G
C
A
C
T
C
A
A
C
T
T
C
G
G
C
-
 
I
G
R
J
a
1
2
 
P
B
L
2
 
A
T
A
C
T
C
A
C
G
G
G
A
G
G
A
G
G
A
A
A
C
A
A
A
C
T
C
A
C
C
T
T
T
G
G
G
-
 
J
A
2
1
0
 
P
B
L
3
 
A
A
T
T
C
A
G
G
A
A
A
C
A
C
A
C
C
T
C
T
T
G
T
C
T
T
T
G
G
A
-
 
J
e
F
 
P
B
L
3
 
G
G
C
A
G
G
A
G
A
G
C
A
C
T
T
A
C
T
T
T
T
-
 
J
~
6
P
a
2
 
P
B
L
4
 
A
C
T
A
T
C
A
G
T
T
A
A
T
C
T
G
G
G
G
C
-
 
I
G
R
J
a
1
4
 
P
B
L
4
 
T
C
R
s
 
w
e
r
e
 
a
m
p
l
i
f
i
e
d
 
f
r
o
m
 
e
D
N
A
 
b
y
 
P
C
R
 
u
s
i
n
g
 
V
~
x
7
.
2
 
a
n
d
 
C
o
e
 
p
r
i
m
e
r
s
 
a
n
d
 
m
u
l
t
i
p
l
e
 
i
s
o
l
a
t
e
s
 
w
e
r
e
 
s
e
q
u
e
n
c
e
d
.
 
T
h
e
 
m
a
j
o
r
i
t
y
 
c
o
n
t
a
i
n
e
d
 
t
h
e
 
p
r
e
c
i
s
e
 
V
a
7
.
2
-
I
G
R
J
a
1
4
 
j
o
i
n
t
 
a
n
d
 
o
n
l
y
 
t
h
e
 
s
i
x
-
b
a
s
e
 
(
t
w
o
-
a
m
i
n
o
 
a
c
i
d
)
 
V
-
J
 
j
u
n
c
t
i
o
n
a
l
 
s
e
q
u
e
n
c
e
s
 
a
r
e
 
s
h
o
w
n
 
f
o
r
 
t
h
e
s
e
.
 
A
l
l
 
o
f
 
t
h
e
 
o
t
h
e
r
 
i
s
o
l
a
t
e
s
 
a
l
s
o
 
c
o
n
t
a
i
n
e
d
 
f
u
n
c
t
i
o
n
a
l
 
r
e
a
r
r
a
n
g
e
m
e
n
t
s
 
a
n
d
 
t
h
e
 
N
 
r
e
g
i
o
n
 
a
n
d
 
5
'
 
e
n
d
 
o
f
 
t
h
e
 
J
 
r
e
g
i
o
n
 
a
r
e
 
s
h
o
w
n
 
f
o
r
 
t
h
e
s
e
 
V
o
t
7
.
2
 
T
C
R
s
.
 
T
h
e
 
V
A
T
.
2
 
s
e
q
u
e
n
c
e
 
i
n
 
a
l
l
 
o
f
 
t
h
e
s
e
 
e
x
t
e
n
d
e
d
 
t
o
 
t
h
e
 
T
G
T
G
C
T
 
(
c
y
s
a
l
a
)
 
i
n
d
i
c
a
t
e
d
 
a
s
 
t
h
e
 
3
'
 
e
n
d
 
o
f
 
t
h
i
s
 
V
o
t
 
g
e
n
e
 
i
n
 
T
a
b
l
e
 
2
.
 
T
h
e
 
s
e
q
u
e
n
c
e
s
 
s
h
o
w
n
 
h
e
r
e
 
d
o
 
n
o
t
 
i
n
c
l
u
d
e
 
t
h
o
s
e
 
s
h
o
w
n
 
i
n
 
T
a
b
l
e
 
2
 
f
r
o
m
 
d
o
n
o
r
s
 
1
 
a
n
d
 
2
.
 
T
h
e
 
c
o
m
p
l
e
t
e
 
J
o
t
6
P
a
2
 
s
e
q
u
e
n
c
e
 
w
i
l
l
 
b
e
 
r
e
p
o
r
t
e
d
 
e
l
s
e
w
h
e
r
e
 
(
S
.
 
P
.
 
B
a
l
k
,
 
m
a
n
u
s
c
r
i
p
t
 
i
n
 
p
r
e
p
a
r
a
t
i
o
n
)
.
 cloned and sequenced. TCR cr transcripts were amplified by 
PCK from unfractionated  PBLs or DN cx/fl T  cells  using 
an antisense Ca primer and Vex7.2- or Vc~24-specific  sense 
primers.  The amplified TCRs were then cloned into pBlue- 
script  and multiple  isolates were sequenced. 
Table 3 shows the N  region sequence and J  region usage 
ofVa24 TCRs from five donors. In all five DN populations, 
the invariant rearrangement  to JotQ comprised the majority 
of functional TCRs.  In donors  1 and 5, every isolate from 
the DN preparation  had this rearrangement.  The invariant 
Va24-Jc~Q rearrangement was also found in the PBL samples 
from all but one donor, but the frequency of this rearrange- 
ment in the PBLs was in all cases less than in the matched 
DN preparations.  Moreover,  some of the invariant  Vo~24- 
JolQ transcripts  in the unfractionated PBLs were likely de- 
rived from DN cx/fl T cells. These results demonstrated that 
the  invariant  Vcr24-JcxQ  rearrangement  was  enriched  in 
the DN ol/fl T  cell populations of all donors and indicated 
that  some degree of selection for this TCR may also occur 
in  single-positive  T  cells  from  some donors. 
TCRs using Va7.2 were examined similarly to determine 
if the precise rearrangement  to IGRJa14, with two variable 
amino acids in the V-J  junction (see Table 2), was enriched in 
the DN cx/fl T  cell population.  Consistent with the results 
in Table 2, this precise rearrangement  to IGRJa14 was found 
in the majority  (11/12)  of Vc~7.2 TCRs isolated from the 
DN ot/fl T cell preparations (Table 4). However, this Vot7.2- 
IGRJa14 rearrangement was also found in many of the Vc~7.2 
isolates from unfractionated PBLs (8/14),  which contained 
predominantly single-positive T  cells. These results showed 
that the Vot7.2 gene had a marked preference for this partic- 
ular rearrangement to IGRJa14 in the DN c~/fl T cell popu- 
lations and suggested that  a similar bias was present in the 
single-positive T cells from some donors (see also Fig. 4 B). 
Table 4 shows the junctional nucleotides and amino acids 
from each of the precise Vo17.2-IGRJa14 joints isolated. The 
two junctional  amino  acids  were not highly conserved, al- 
though the first one was neutral in all cases and the second 
was neutral or basic. This larger sampling of Vcr7.2 sequences 
also indicated  that  the germline  Vc~7.2  gene probably ex- 
tended past the 3'  alanine  shown in  Table  2  and includes, 
at least, the GTG (valine), which is shown in Tables 2 and 
4  as being part of the N  region.  Furthermore,  the finding 
of GTGAGA (valarg)  at the 3' end of several Vc~7.2 isolates 
(including three that did not have the precise joint to IGRJa14) 
suggested that  this GTGAGA was the actual 3' end of the 
Vex7.2  gene. 
Enrichment of the  Vcr24-JcrQ Rearrangement in DN cr/fl 
Demonstrated by Direct Analysis of  PCR Products  on Denaturing 
Polyacrylamide Gels.  To further support the results in Table 
3, that the predominant Vo~24 rearrangement in the DN cells 
was to JoLQ with no diversity at the V-J joint,  PCR prod- 
ucts generated with the Vex24 primer were analyzed on high- 
resolution denaturing polyacrylamide gels (DNA sequencing 
gels). The PBL or DN cDNA were amplified by PCR ini- 
tially with the Vc~24 primer and a Cc~ primer.  Aliquots of 
Figure 4.  Analysis  of Vo~24  and 
Vc~7.2 transcripts by PCR ampli- 
fication and  gel  electrophoresis. 
cDNA from DN or PBL samples 
were amplified  with a Vex24  primer 
(A) or Vc~7.2  primer (B) and an ex- 
ternal  Ca  primer.  They were 
reamplified using an internal Cot 
primer and labeled  by incorporation 
of cx-[32p]dCTP.  The labeled PCR 
products were then analyzed on a 
6% denaturing polyacrylamide  gel. 
(Lanes  + )  The  template was  a 
plasmid  containing  the  precise 
Vcx24-JcxQjoint  (.4) or the VccT.2- 
IGRJa14 joint  (B). (Lane -) No 
added cDNA or plasmid. 
10  TCR Expression by Human Double-Negative  cx/fl T Cells these PCR products were then reamplified with the Va24 
primer and an internal Cot primer, in the presence of ot.[32p] 
dCTP,  and analyzed on a DNA  sequencing gel. 
The DN ol/fl T cell cDNA from each of the donors yielded 
predominantly a single band (Fig. 4 A). The size of this band 
was identical to the band generated by amplification from 
a plasmid containing the invariant Vot24-JotQ rearrangement. 
In contrast, the matched PBL samples showed a more heter- 
ogeneous banding pattern, consistent with the presence  of 
N  region diversity and usage of multiple J  regions (Fig.  4 
A). These results were in good agreement with the sequencing 
data (Table 3) and supported the conclusion that the invar- 
iant Voc24-JotQ rearrangement was enriched in the DN ot/fl 
T  cell population. 
A similar analysis  was carried out for TCRs using the Vot7.2 
gene (Fig. 4 B). In these experiments all of the DN and PBL 
samples generated a prominent doublet that was identical to 
the doublet generated by amplification from a plasmid con- 
taining the precise Vot7.2-IGRJa14 rearrangement. The bands 
appear as doublets, rather than single bands, due to incom- 
plete addition of a nontemplate-encoded adenosine at the 3' 
end by the Taq polymerase (51). This incomplete addition 
of an adenosine at the 3' has been seen in some PCR amplifica- 
tions, but not all (see Fig. 4 A), and the variables involved 
are not clear. 
Large doublets were also seen at intervals of three bases 
in most samples, indicating that they were derived from func- 
tional V-J rearrangements (Fig.  4 B). The sequencing data 
in Table 4 similarly showed that most Vot7.2 rearrangements 
to Jots other than IGRJa14 were functional. In all cases ex- 
cept one (DNs from donor 3), these additional bands were 
significantly  less intense than the Vot7.2-IGRJa14 rearrange- 
ment, particularly in the DN preparations from donors 1, 
2, 4, and 5. These results demonstrated that the Vot7.2 gene 
had a very strong bias towards one particular type of rear- 
rangement in both the DN and single-positive T cell popu- 
lations, with an even more pronounced bias in the DN oe/fl 
T  cell population from some, but not all,  donors. 
Quantitative PeR  Analysis of Vj8 Usage by ON cr/B  T 
Cells.  Further evidence that certain TCRs are used prefer- 
entially by DN ot/fl T  cells was provided by an analysis of 
Vfl expression. Quantitative PCR amplification was performed 
Figure  5.  Quantitative  PCR amplification  analysis of Vfl expression 
by DN oc/fl T cells and PBLs. PBL and DN ot/fl T cell cDNA from 
donors 1 and 3 were  amplified  by PCR for 30 cycles  with a series  of  primers 
specific for Vfll-20 and the products were hybridized  with an internal 
oligonucleotide  probe, as described  in Materials  and Methods.  The sources 
of the cDNA and the Vfl primers are indicated. 
on unfractionated PBLs and DN ot/fl T  cells from donor 
1,  using a panel of primers specific for Vfll-20 and a  Cfl 
primer specific for Cfll and Cfl2. Fig. 5 shows that the pat- 
tern of Vfl usage by the PBLs versus  the DN ot/fl T  cells 
was significantly different. In particular,  there was clearly en- 
richment for Vfl2 and Vflll in the DN ot/fl T  cell popula- 
tion versus  the PBLs from this donor. 
A similar analysis from a second donor is shown in Fig. 
5, and the results from analyses of all five donors are summa- 
rized in Table 5. These data showed a marked preference  for 
the use of one or several Vfl genes in every donor. Moreover, 
the dominant Vfl gene families expressed by every donor were 
Vfl2, 8,  11, or 13. These results supported the conclusion 
that DN oL/fl T cells used certain TCRs preferentially. The 
Table  5.  Quantitative  PCR Analysis of V~ Expression by DN cr/~ T Cells  from Pe@heral  Blood of Normal Donors 
TCR Vfl 
Donor  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 
% 
1  DN  1  18  4  5  12  1  9  6  1  1  36  3  1  0  0  0  0  0  0  0 
2 DN  0  16  3  5  0  0  0  0  0  0  0  1  72  1  0  0  0  1  0  0 
3 DN  1  8  7  2  1  5  7  37  3  1  15  2  8  1  0  0  0  0  0  0 
4 DN  0  7  0  0  0  0  1  73  4  1  1  2  2  1  0  0  7  0  0  0 
5 DN  0  26  0  0  3  0  2  6  1  1  33  3  16  2  2  1  3  0  0  0 
11  Porcel~  et al. finding of similar VB gene usage in multiple unrelated donors 
further suggested that polymorphisms  in the classical MHC 
class I and II molecules did not influence the selection of V~ 
genes by these cells. Additional studies will be needed to de- 
termine if TCR ~ chains using these predominant V3 genes 
pair with invariant TCR ot chains or TCR o~ chains with 
other distinct structural features. 
Assessment  of v/~ Heterogendty  by High-Resolution  PAGE.  A 
gel electrophoresis method was used to determine whether 
the TCR-B chains using predominant V~s from each donor 
were monoclonal or multiclonal. The TCRs were amplified 
by PCR with V~2, 8,  11, or 13 primers and a C~3 primer. 
The PCR. products were then reamplified with the same VB 
primer and an internal, 32p-labeled Cj3 primer, and analyzed 
by gel electrophoresis.  PBL cDNA was analyzed  similarly 
with each Vfl primer. 
The PBL cDNA yielded multiple bands with each V~ 
primer (Fig. 6), indicative of differences in length of the N 
region in a polyclonal population. The major PBL bands were 
all separated by three bases, consistent with most TCR tran- 
scripts being derived from functional rearrangements. A similar 
pattern was seen for the DN TCR B chains using VBll, in- 
dicating that multiple DN  ol/B T  cell clones  using VBll 
were present. In contrast,  several predominant bands were 
detected among the DN TCR B chains using V~2, 8, and 
13, suggesting an oligoclonal expansion of T cells using these 
VBs. Taken together, the results of these analyses indicated 
that DN ~/~ T cells preferentially expressed particular V~s, 
with V/~2, 8,  11, and 13 being over represented, and sug- 
gested that diversity at the Vfl-Jfl joint in DN a/B T cells 
using some Vfl genes was also limited compared with PBLs. 
Sequencing of multiple DN TCR B chains will be required, 
however, to determine precisely the complexity of TCR 
chains expressed by DN a/B T  cells. 
Discussion 
Human peripheral blood contains a small population of 
DN o~/B T  cells, but whether these cells are functionally 
or developmentally distinct from their CD4- or CDS-positive 
counterparts has not been dear. The data presented here dem- 
onstrate significant  differences between the TCR oL and j3 
chains used by DN and single-positive  o~/B T  cells in the 
peripheral blood of normal human donors. The expression 
of one particular TCR c~ chain, a rearrangement between 
Vo~24 and Jo~Q with no diversity at the V-J joint, was in- 
creased in the DN ol/B T  cells from all five donors exam- 
ined. The preferential use of certain VB genes was also found 
in all five donors. These results indicate that DN c~/~ T cells 
may arise through a different pathway of T cell development 
or be selected for recognition of different ligands than single- 
positive o~//~ T  cells. 
The invariant Vc~24-Jo~Q TCR found increased in each 
DN o~/B T  cell preparation was most likely  generated by 
the removal of two bases from the germline  J~Q gene, with 
no N  region additions. These invariant  voL24-JolQ TCRs 
could be derived from a single expanded clone in each donor, 
but their occurrence in all donors suggests that this rearrange- 
ment occurs in multiple independent clones in each donor. 
Examples of invariant  TCR chains with no N region addi- 
tions have been described for certain 3'/~ T cells. Murine den- 
dritic epidermal T cells (DECs) express invariant TCR 3' and 
chains  that are generated by independent recombination 
events in multiple clones (52, 53). In humans, a significant 
proportion of the  joints between V79 and JTP are generated 
by the excision of a single J'yP-encoded base, with no N re- 
gion additions (54).  Whether this invariant  V79-JTP rear- 
rangement occurs in one or multiple independent clones has 
not been determined. 
The relatively high frequency of these invariant Vc~24-Jo~Q 
TCRs in multiple donors indicates that some mechanism exists 
that favors their occurrence.  Although this mechanism may 
be simply positive selection  of randomly generated clones, 
a number of factors could increase the frequency of this rear- 
rangement directly. For example, the germline V~24 andJo~Q 
genes may be particularly accessible to each other due to close 
physical proximity or because they become activated for recom- 
bination at the same time during development. The lack of 
template-independent insertions in the invariant Vo~24-Jo~Q 
TCR could be due to development of DN ol/~ T  cells in 
Figure  6.  Analysis of VB tran- 
scripts by PCR amplification and gel 
electrophoresis,  eDNA was ampli- 
fied with  Vj3 primers and  a  CB 
primer and then reamplified using 
an internal, a2p-labeled CB primer. 
The  labeled PCR  products  were 
analyzed on a 6% denaturing poly- 
acrylamide gel.  The  V~  primers 
used and the sources of the cDNA 
are indicated. 
12  TCR Expression by Human  Double-Negative ~x/j3 T  Cells the thymus before TdT is active, as is the case for the invar- 
iant TCR 3' and/t chains of murine DECs (55,  56). If the 
high frequency of the invariant Vt~24-Jc~Q joint is indeed 
due to these or other mechanisms operating to favor invar- 
iant Vot-Jot recombinations in DN or//3 T cells, then TCKs 
with other invariant germline Vc~-Jc~  joints may be present 
and predominate in the DN or/3 T cells from other donors. 
Random TCR c~ cloning from additional DN or/3 T  cell 
preparations and further information on genomic Vot and 
Jot sequences will be necessary to address this question. 
An alternative possibility is that invariant Vct24-JctQjoints 
could be generated at random in the thymus and then un- 
dergo positive selection followed by ligand-dependent donal 
expansion in the periphery. The ligands recognized by DECs 
or by TCtLs using the invariant Vot24-JaQ or V3'9"Jq'P rear- 
rangements have not been identified. The expression of the 
Vct24-JctQ TCR in multiple donors suggests that the ligand, 
or at least the epitope, recognized by this TCR is nonpoly- 
morphic. Similar arguments have been made for the ligands 
recognized by DECs (52, 53, 57) and the Vq'9-J3'P recombi- 
nation (54). If the ligand recognized by the vot24-JolQ TCR 
is an MHC class I or II molecule or a nonpolymorphic  MHC 
class I-like molecule, then the lack of CD4 or CD8 expres- 
sion may be necessary to prevent autoreactivity. Analysis of 
T  cell clones using this invariant Vc~24-Jc~Q TCR will be 
necessary to identify the ligand recognized by this TCR and 
determine if it arises in multiple independent clones in each 
donor. 
A  second interesting group of TCR o~ chains identified 
in these studies were recombinations between Vct7.2 and 
IGRJa14. These Vc~7.2-IGRJa14joints were enriched in some, 
but not all, DN a/B T  cell preparations. In the majority 
of DN c~//~ T cells and unfractionated PBLs using VotT.2, 
the joint was to the same nucleotide in IGRJa14 with two 
variable amino acids in the V-J junction. The conserved struc- 
ture of this Vct7.2-IGRJa14 joint in multiple clones from 
five donors suggests that this TCR a  chain may be selected 
by a nonpolymorphic ligand. Nonpolymorphic MHC class 
I-like (58) or class II-like (59, 60) molecules are candidate 
ligands, as these Vc~7.2-IGRJa14 TCRs are expressed  by single- 
positive as well as DN T cells. Alternatively, the Vc~7.2 gene 
may have a structural limitation such that only these partic- 
ular recombinations with IGRJa14 allow it to fold correctly 
and undergo positive selection by conventional MHC mole- 
cules. A similar recombination between murine Vot14 and 
Jol281 with a one-base  N  region has been demonstrated in 
multiple strains of mice, and these TCRs appear to be positively 
selected by a non-MHC-linked monomorphic ligand (61). 
The analysis of TCR ~ chains provided further evidence 
that DN ot/~ T cells use particular TCRs preferentially. The 
majority of DN c~/B T cells from each donor used only one 
or two VB gene families, with the predominant VBs being 
V~2, 8, 11, and 13 (Table 5). Further analysis of these TCR 
chains on DNA sequencing gels indicated that they were 
less heterogeneous than the corresponding TCRs from PBLs. 
This suggests that their expansion was probably not due to 
VB-specific polyclonal stimulation by a superantigen (62), 
although the possibility that chronic stimulation by super- 
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antigens might result in this pattern of restricted TCR 
expression cannot be ruled out. The preferential expression 
of these V/3s by DN t~/~ T  cells from multiple unrelated 
donors suggests, therefore,  that these cells may recognize a 
limited number of conventional antigens and may use non- 
polymorphic antigen-presenting molecules. Alternatively, if 
the TCR B chains using these predominant VBs are paired 
with invariant TCR c~ chains or other TCR cr chains with 
particular structural features,  then the ability to pair with 
these TCR ot chains could be the major factor responsible 
for selecting these V/~s. 
Normal mice also have a small population of mature DN 
ct//3 T cells (10-19) that preferentially use the V~8 gene family 
(10-12, 14, 16), but the function of these cells and their rela- 
tionship to single-positive ct/B T cells have not been resolved 
(16, 19, 22, 23, 63, 64). Studies of the CDdct gene in DN 
ol/B cells have shown that this gene is demethylated at some 
sites, providing evidence that it was expressed at one point 
by these cells (16, 65). However, the demethylation pattern 
appears to be less complete in DN ot/B thymocytes than in 
CD4 single-positive  cells, suggesting that DN c~//3 T cells 
never fully expressed the CDdct gene (65). A recent report 
demonstrates  that  CD4-CD8 l~ thymocytes, which  have 
been proposed as the immediate precursors  of CD4 +  CD8 + 
thymocytes, express low levels of functional ot/~ TCRs and 
that ligation of their TCRs blocks their expression of CD4 
and CDd, but does not lead to cell death (66). Taken together, 
these observations suggest that CD4-CD81~ thymocytes ex- 
pressing TCRs with a high affinity for some intrathymic an- 
tigens could be the precursors of mature DN ot/~ T cells (67). 
The antigens recognized by murine DN o~/B T cells have 
not been identified, but candidate ligands for these cells in 
humans are the MHC-like CDla, b, and c proteins, which 
are expressed by immature thymocytes (68-70). DN c~//3 T 
cell clones that specifically lyse target cells expressing CDla 
(4, 32) or CDlc (4), with no apparent requirement for an 
exogenous antigen, have been isolated from human periph- 
eral blood. A possible function for such CDl-specific DN 
t~/B T  cells could be the elimination of malignant or au- 
toimmune immature T cells that escape from the thymus into 
the periphery. DN or//3 T cells that display CDlb-restricted 
recognition of a processed mycobacterial  antigen have also 
been described (4), suggesting a role for these cells in immu- 
nity to microbial pathogens. Our finding that TCRs expressed 
by DN or//3 T cells have restricted V gene usage and distinc- 
tive structural features in their V-J junctions, in conjunction 
with these observations on CD1 recognition, provide fur- 
ther evidence for the hypothesis that a significant proportion 
of T cells lacking CD4 and CD8 recognize antigen-presenting 
molecules other than the classical MHC class I and II proteins. 
DN ct//5 T cells are increased in some patients with SLE 
(2) and systemic sclerosis (6), and restricted VB gene usage 
has been reported in the latter disease (6). However, the rela- 
tionship between these DN ct/B T cells in autoimmune dis- 
eases and in normal peripheral blood is unclear, nor is it known 
if DN or//3 T  cells play a direct causative role in these dis- 
eases. Mice with the Ipr defect, caused by a mutant Fas gene 
(71), similarly have a SLE-like disease and greatly increased numbers of DN el/fl T  cells (8). This suggests that expan- 
sion of DN c~/fl T  cells in some cases may be secondary to 
an underlying immunological defect causing autoimmunity, 
rather than a primary cause of the disease. Nevertheless, fur- 
ther studies on the relationship between expansion of DN 
c~/fi T cells and autoimmune disease are warranted and could 
lead to important insights into the function of these cells. 
The data in this report on the structure of the TCRs ex- 
pressed by DN oe//3 T cells in normal peripheral blood pro- 
vide a useful baseline against which the structure of these 
TCRs in various diseases  can be compared. 
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